Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women

Climacteric

Volumn 15, Issue 4, 2012, Pages 350-357

  Lambrinoudaki, I ^a   Augoulea, A ^a   Armeni, E ^a   Rizos, D ^a   Alexandrou, A ^a   Creatsa, M ^a   Kazani, M ^b   Georgiopoulos, G ^b   Livada, A ^c   Exarchakou, A ^c   Stamatelopoulos, K ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS   (Greece)

Author keywords

CARDIOVASCULAR RISK; MENOPAUSAL SYMPTOMS; POSTMENOPAUSE; SUBCLINICAL ATHEROSCLEROSIS

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; ANDROGEN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GREENE CLIMACTERIC SCALE; HOT FLUSH; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PULSE WAVE; RATING SCALE; SMOKING; SUBCLINICAL ATHEROSCLEROSIS; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ANALYSIS OF VARIANCE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PULSE WAVE ANALYSIS;

EID: 84863599117     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.618564     Document Type: Article

References (44)

1. Freedman RR, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril 1996;65:1141-4
2. Kronenberg F. Hot fl ashes: Phenomenology, quality of life, and search for treatment options. Exp Gerontol 1994;29:319-36
3. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot fl ashes. Am J Obstet Gynecol 1999;181:66-70
4. Rossmanith WG, Ruebberdt W. What causes hot flushes' The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecol Endocrinol 2009;25:303-14
5. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot fl ashes. Menopause 2005;12:258-66
6. Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997;3:103-20
7. Gold EB, Sternfeld B, Kelsey JL, et al . Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40 - 55 years of age. Am J Epidemiol 2000;152:463-73
8. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot fl ashes. J Womens Health 1998;7:1149-55
9. Whiteman MK, Staropoli CA, Langenberg PW, McCarter RJ, Kjerulff KH, Flaws JA. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol 2003;101:264-72
10. Thurston RC, Sowers MR, Chang Y, e t al . Adiposity and reporting of vasomotor symptoms among midlife women: The Study of Women' Health Across the Nation. Am J Epidemiol 2008;167: 78-85
11. Thurston RC, Sowers MR, Sutton-Tyrrell K, e t al . Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-34
12. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: The evidence. Climacteric 2007; 10(Suppl 1):19-24
13. Manson JE, Allison MA, Rossouw JE, e t al . Estrogen therapy and coronary-Artery calcifi cation. N Engl J Med 2007;356: 2591-2602
14. Stampfer MJ, Colditz GA, Willett WC, e t al . Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-62
15. Grady D, Rubin SM, Petitti DB, et al . Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37
16. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-41
17. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53: 605-19
18. Hodis HN, Mack WJ. Postmenopausal hormone therapy and cardiovascular disease in perspective. Clin Obstet Gynecol 2008; 51:564-80
19. Martin KA, Manson JE. Approach to the patient with menopausal symptoms. J Clin Endocrinol Metab 2008;93:4567-75
20. LaCroix AZ, Chlebowski RT, Manson JE, e t al . Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial. JAMA 2011;305:1305-14
21. Gast GC, Grobbee DE, Pop VJ, et al . Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51:1492-8
22. Manson JE, Hsia J, Johnson KC, e t al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349: 523-34
23. Allison MA, Manson JE, Aragaki A, et al . Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause 2010;17:1136-45
24. Fabris F, Zanocchi M, Bo M, e t al . Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke 1994;25:1133-40
25. Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998;29:1116-21
26. Li R, Duncan BB, Metcalf PA, et al . B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke 1994;25: 2377-2383
27. Yu RH, Ho SC, Ho SS, Chan SS, Woo JL, Ahuja AT. Carotid atherosclerosis and the risk factors in early postmenopausal Chinese women. Maturitas 2009;63:233-9
28. Stein JH, Korcarz CE, Post WS. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: Summary and discussion of the American Society of Echocardiography consensus statement. Prev Cardiol 2009;12: 34-38
29. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. B r J Clin Pharmacol 2001;51:507-22
30. Tomiyama H, Yamashina A. Non-invasive vascular function tests: Their pathophysiological background and clinical application. Circ J 2010;74:24-33
31. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: Fi ndings from the Study of Women' Health Across the Nation Heart Study. Circulation 2008;118:1234-40
32. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Powell LH, Matthews KA. Hot flashes and carotid intima media thickness among midlife women. Menopause 2011;18:352-8
33. Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcifi cation among postmenopausal women. Menopause 2010;17:256-61
34. Bechlioulis A, Kalantaridou SN, Naka KK, et al . Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199-206
35. Clapauch R, Mecenas AS, Maranhao PA, Bouskela E. Endothelialmediated microcirculatory responses to an acute estradiol test are infl uenced by time since menopause, cumulative hormone exposure, and vasomotor symptoms. Menopause 2010;17: 749-57
36. Mattace-Raso FU, Hofman A, Verwoert GC, e t al . Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: Establishing normal and reference values' . Eur Heart J 2010;31:2338-50
37. Gast GC, Samsioe GN, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profi le in women. Maturitas 2010;66:285-90
38. Leal M, Diaz J, Serrano E, Abellan J, Carbonell LF. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol 2000;95:804-9
39. Sassarini J, Fox H, Ferrell W, Sattar N, Lumsden MA. Vascular function and cardiovascular risk factors in women with severe fl ushing. Clin Endocrinol (Oxf) 2011;74:97-103
40. Tuomikoski P, Mikkola TS, Hamalainen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot fl ashes. Menopause 2010;17:145-51
41. Hoikkala H, Haapalahti P, Viitasalo M, et al . Association between vasomotor hot flashes and heart rate variability in recently postmenopausal women. Menopause 2010;17:315-20
42. Tuomikoski P, Ebert P, Groop PH, e t al . Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol 2009;113:902-8
43. Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on postmenopausal hormone therapy. Ann Med 2010;42:334-43
44. Tuomikoski P, Ylikorkala O, Mikkola TS. Menopausal hot flushes and vascular health. Ann Med 2011;43:283-91